Samyr 400 mg tablets

Samyr 400 mg tablets are a pharmaceutical product containing 400 mg of ademetionine, an active ingredient known for its antidepressant properties. Ademetionine, also known as S-adenosyl-L-methionine, is a naturally occurring molecule in the human body that plays a crucial role in various metabolic processes, including the synthesis of neurotransmitters such as serotonin and dopamine. These neurotransmitters are essential for mood regulation, and their balanced levels are vital for mental health. The tablets are primarily manufactured in multiple countries, ensuring a broad distribution and availability. The brand 'Samyr' is associated with this product, and it is marketed under this name in various regions. The ultimate owner company of the Samyr brand is Mylan S.p.A., an Italian pharmaceutical company that specializes in the production and distribution of generic and specialty medicines. Mylan S.p.A. is headquartered in Italy and operates globally, providing a wide range of pharmaceutical products. In the United States, the distribution and marketing of Samyr 400 mg tablets are managed by Mylan Pharmaceuticals Inc., a subsidiary of Mylan S.p.A. This subsidiary is responsible for ensuring the availability and accessibility of Samyr products to the American market.